Author： Richards A. Mark
Publisher： NRC Research Press
ISSN： 1205-7541
Source： Canadian Journal of Physiology and Pharmacology, Vol.89, Iss.8, 2011-08, pp. : 603-607
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Metabolic Therapy of Heart Failure
Current Pharmaceutical Design, Vol. 14, Iss. 25, 2008-09 ,pp. :
Access to resources
Recommend
-Blocker therapy in heart failure reviewed
Inpharma, Vol. 1, Iss. 1327, 2002-01 ,pp. :
Remodeling as an End-Point in Heart Failure Therapy
By Cohn Jay
Cardiovascular Drugs and Therapy, Vol. 18, Iss. 1, 2004-01 ,pp. :
Intravenous Vasodilator Therapy in Congestive Heart Failure
By Moazemi K. Chana J.S. Willard A.M. Kocheril A.G.
Drugs & Aging, Vol. 20, Iss. 7, 2003-01 ,pp. :